期刊
CHEMICAL BIOLOGY & DRUG DESIGN
卷 74, 期 5, 页码 439-448出版社
WILEY
DOI: 10.1111/j.1747-0285.2009.00883.x
关键词
apoptosis; cancer; cellular fingerprint; in silico screening; Lipinski's-Rule-of-Five
资金
- Deutsche Krebshilfe
- SFB449
- Investitionsbank Berlin-Brandenburg
The cellular fingerprint, a novel in silico screening approach, was developed to identify new biologically active compounds in combination with structural fingerprints. To this end, high-throughput screening (HTS) data from the National Cancer Institute have been used. To validate this method, we have selected the proapoptotic, natural compound betulinic acid (BA). Because of its antiproliferative effect on a variety of cancer cell lines, the identification of novel BA analogs is of great interest. Novel analogs have been identified and validated in different apoptosis assays. In addition, the novel approach exhibited a strong correlation between structural similarity and biological activity, so that it offers enormous potential for the identification of novel biologically active compounds.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据